ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983